Sonoma Pharmaceuticals, Inc. (SNOA) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Find Sonoma Pharmaceuticals, Inc. (SNOA) short-term stock forecasts for 2025 by month and long-term price predictions for 2025 to 2050. View past performance, analyst Buy, Sell or Hold ratings, and the latest SNOA stock news and headlines.
1 Month Prediction
$6.11 [73.01%]
3 Month Prediction
$6.79 [92.22%]
6 Month Prediction
$6.07 [71.97%]
1 Year Prediction
$6.24 [76.73%]
3 Year Prediction
$1.00 [-71.67%]
5 Year Prediction
$1.00 [-71.67%]
About Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals, Inc. is a healthcare company that develops and produces stabilized hypochlorous acid (HOCl) products. The company's products are used in products are used in wound care, eye, oral and nasal care, dermatological conditions, podiatry, animal health care, and non-toxic disinfectants.
Their proprietary Microcyn® Technology has helped in improving outcomes for over ten million patients by reducing infection, itch, pain, scarring, and harmful inflammatory responses.
The company's key products include GramaDerm for acne treatment, Epicyn for scar gel, and Pediacyn for pediatric care. Their products are sold directly or through partners in over 55 countries. Also, the company has manufacturing facilities in Guadalajara, Mexico, and European marketing operations in Roermond, Netherlands.
The company was founded in 2005, and is headquartered in Boulder, Colorado.
Sonoma Pharmaceuticals, Inc. (SNOA) Historical Performance
IPO Date
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) went public on 25 January, 2007.
Change
Since inception, SNOA has decreased by 99.99%. In the last 5 years, SNOA has fallen from $101.60 to $3.53, a massive -96.53% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $194.00 and a low of $2.27.
52 Week Range
$1.9
$9.4
The current price $3.53 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
SNOA Stock Price History
Based on SNOA stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the SNOA stock has fallen from $98.0 - $194.0 to $2.27 - $3.53, which is down -97.75%. Currently, the stock follows downward trend.
Here, we have calculated stock range of SNOA, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $98.0 - $194.0 | $139.33 | 10.6 | 1 Year Change |
| 2021 | $91.2 - $163.6 | $134.47 | 6.74 | 2 Year Change |
| 2022 | $22.4 - $80.2 | $54.45 | -56.78 | 3 Year Change |
| 2023 | $3.2 - $33.2 | $16.82 | -86.65 | 4 Year Change |
| 2024 | $2.68 - $7.4 | $3.63 | -97.12 | 5 Year Change |
| 2025 | $2.27 - $3.53 | $2.83 | -97.75 | 6 Year Change |
SNOA Price Performance
6-Month Performance
SNOA stock jumped by 31.72% in the last six months.
1-Year Performance
The stock has trended upwards by 10.31% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 93.36%.
5-Year Performance
In the last 5 years, the stock has gone down by 96.53%.
According to Sonoma Pharmaceuticals, Inc.'s historical data, below graph gives us the exact picture of how the SNOA stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 1 year and a decline in 4 years.
2020
66.51% ↑
2021
37.19% ↓
2022
75.44% ↓
2023
83.93% ↓
2024
25.28% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Sonoma Pharmaceuticals, Inc. (SNOA) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $3.56 M (Q4)
Revenue for Q4 ending 31st December, 2024 decreased 0.42% compared to Q3 ending 30th September, 2024.
Annual Revenue: $13.97 M (1Y)
Revenue for trailing 12 months increased 9.72% year over year from 31st March, 2024.
Market Capitalization
Sonoma Pharmaceuticals, Inc. has a market capitalization of $5.70M, which places SNOA in the nano-cap category.
Fundamental Analysis
EPS: $-0.63 (Q4), $-10.60 (1Y)
EPS increased 6.78% since last quarter, and decreased 65.13% since last year.
Net Income: $-928.00 T (Q4), $-4.83 M (1Y)
Net Income increased 52.13% since last quarter, and decreased 6.13% since last year.
Free Cash Flow: $563.00 T (Q4), $-2.42 M (1Y)
Free Cash Flow increased 71.65% since last quarter, and decreased 62.39% since last year.
Net Profit Margin: -26.04% (Q4), -34.60% (1Y)
Net Profit Margin increased 52.77% since last quarter, and decreased 14.45% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for SNOA stock. These indicators help you understand Sonoma Pharmaceuticals, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for SNOA stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $2.53 |
| SMA50 | $2.61 |
| SMA200 | $3.62 |
| RSI | 69.23 |
| Beta | 1.56 |
SMA20 < Current Price
This signals SNOA stock is in short-term bullish momentum.
SMA50 < Current Price
This signals SNOA stock is in mid-term bullish momentum.
SMA200 > Current Price
This signals SNOA stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for SNOA stock is Neutral. Out of all indicators, 3 indicates bullish signals, 3 signals bearish trends and 3 gives neutral trends. The SNOA stock forecast was last updated on 17 March, 2025.
Sonoma Pharmaceuticals, Inc. (SNOA) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to fall to $2.75 by the end of 2025, and can reach around $9.46 to $9.99 in 2026. And, the long-term forecast suggests that the stock may further drop to $0.99 - $0.94 in 2028, and $0.87 - $0.76 by 2031. So, the SNOA stock shows a strong downward trend in the next several years.
Short-term SNOA Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-04 | $6.11 | 73.09% |
| 2025-05 | $6.66 | 88.67% |
| 2025-06 | $6.79 | 92.35% |
| 2025-07 | $10.05 | 184.7% |
| 2025-08 | $6.12 | 73.37% |
| 2025-09 | $6.07 | 71.95% |
| 2025-10 | $1.00 | -71.67% |
| 2025-11 | $1.21 | -65.72% |
| 2025-12 | $2.75 | -22.1% |
In 2025, the SNOA stock price is expected to fluctuate between $1.0 and $10.05. According to the monthly forecast, the stock could drop to $2.75 by December 2024. If compared to the SNOA's current price, the stock could lose -22.1% by the end of this year.
Long-term SNOA Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $9.46 | $3.63 | $9.99 | 183.0% |
| 2027 | $10.78 | $0.95 | $0.99 | -71.95% |
| 2028 | $0.99 | $0.83 | $0.94 | -73.37% |
| 2029 | $1.31 | $1.14 | $1.52 | -56.94% |
| 2030 | $1.13 | $1.28 | $1.47 | -58.36% |
| 2031 | $0.87 | $0.69 | $0.76 | -78.47% |
| 2032 | $0.76 | $0.89 | $1.09 | -69.12% |
| 2033 | $1.21 | $1.42 | $0.70 | -80.17% |
| 2034 | $0.87 | $0.46 | $0.74 | -79.04% |
| 2035 | $0.82 | $1.28 | $1.37 | -61.19% |
| 2036 | $1.01 | $0.48 | $0.96 | -72.8% |
| 2037 | $0.73 | $1.21 | $0.91 | -74.22% |
| 2038 | $0.69 | $0.83 | $1.03 | -70.82% |
| 2039 | $0.46 | $0.46 | $0.73 | -79.32% |
| 2040 | $1.74 | $0.60 | $0.90 | -74.5% |
| 2041 | $1.28 | $1.05 | $1.76 | -50.14% |
| 2042 | $0.96 | $0.89 | $0.50 | -85.84% |
| 2043 | $0.69 | $0.81 | $0.79 | -77.62% |
| 2044 | $1.21 | $0.89 | $1.01 | -71.39% |
| 2045 | $0.92 | $1.41 | $0.76 | -78.47% |
| 2046 | $1.02 | $1.30 | $0.97 | -72.52% |
| 2047 | $0.29 | $0.75 | $0.24 | -93.2% |
| 2048 | $0.55 | $0.97 | $0.70 | -80.17% |
| 2049 | $0.96 | $0.86 | $1.38 | -60.91% |
| 2050 | $0.63 | $1.29 | $1.05 | -70.25% |
| 2051 | $0.73 | $0.81 | $1.39 | -60.62% |
Sonoma Pharmaceuticals, Inc. (SNOA) Stock Price Prediction & Forecast 2025
At the start of 2025, the SNOA stock was at $2.69. Today, it is trading at $3.53, which is 31.23% increase from price at the beginning of the year. By the end of this year, you can expect the stock to fall to $2.75 by December 2025 with a -22.10% change.
Sonoma Pharmaceuticals, Inc. (SNOA) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the SNOA stock. During this period, the SNOA's price is forecasted to shift from $9.46 to $1.47, which is -84.46% loss.
In 2026, the stock would possibly open at $9.46, descends to $3.63 by mid-year, and wraps up at $9.99, reflecting a 182.94% increase from today's price. Further moving to 2030, the stock can kick off the year at $1.13, drop to $1.28 by mid-year, and finish at $1.47, which is -58.43% change from current price.
Sonoma Pharmaceuticals, Inc. (SNOA) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $0.87 to $0.90, which is up -78.44%
In 2031, we can expect SNOA to fluctuate between $0.76 and $0.87, a shift indicating a -78.44% loss by year-end compared to current price. And Until 2040, SNOA can likely vary from $0.90 to $1.74. By the end of 2040, the stock could record a -74.58% fall from today's stock price.
Sonoma Pharmaceuticals, Inc. (SNOA) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the SNOA stock can see an a downturn from $1.28 to $1.05 in this period. In 2041, the stock can experience a low of $1.05 by mid-year, closing the year at $1.76. This results in a -70.16% decrease from today.
Moving towards the end of 2050, SNOA is projected to open the year at $0.63. The stock may peak to $1.29 during mid-year and finish the year at $1.05. Compared to the stock's current price, this translates to an overall loss of -70.19% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
SNOA Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| GTBIF | Green Thumb Industries Inc. | - | $6.75 | -2.88% ▼ | $194.39 ▲ |
| TLRY | Tilray Brands, Inc. | - | $0.65 | -12.08% ▼ | $293.75 ▲ |
Last updated Mar 17 at 12:13 PM
SNOA : Buy, Sell Or Hold?
Analyst Ratings
Based on 1 analysts, 0 rated as a strong buy, 1 recommended a buy, 0 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.So, according to analyst ratings, the recommendation for SNOA stock is Buy.
Expert Analysis
According to SNOA short-term and long-term forecast, Sonoma Pharmaceuticals, Inc. shares are projected to go down by 70.25%, and reach a value of $1.05 per share by 2050.
As per technical analysis, indicators show a Neutral sentiment, while Fear & Greed Index stands at 35.714285714285715, which signals Fear. Also, SNOA has recorded 8/30 green days, which reflects a 36.36363636363637% positivity rate with a price volatility of 0.10%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that SNOA stock is undervalued. So, Based on SNOA prediction and analysis, it may be the best time to hold SNOA stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "SNOA” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.